Monday, November 16, 2026
23.3 C
Bengaluru

Indian Pharma November Sales: What Do They Say?

IQVIA's Market Feedback Report (MFR) and PharmaTrac's Acquaint report both analyze the Indian Pharmaceutical Market (IPM) for November 2025, revealing consistent growth trends driven by chronic therapies despite minor data discrepancies.

MFR reports MAT sales at ₹246,846 Cr with 8.2% growth, while PharmaTrac shows ₹238,968 Cr at 8.8% YoY and 8.8% 5-year CAGR. Critical analysis highlights strong chronic momentum but questions volume sustainability amid price hikes and new launches.[1][2]

Market Growth Comparison

MetricIQVIA MFR (MAT Nov25) [1]PharmaTrac Acquaint (MAT Nov25) [2]Total IPM Value₹246,846 Cr (8.2% growth)₹238,968 Cr (8.0% YoY, 8.8% CAGR)Monthly Nov25 Sales₹21,679 Cr (8.6% MoM adjusted)₹21,182 Cr (9.1% YoY)Incremental ValueNot specified₹1,759 Cr YoYAcute Growth6.3%5.4% (44% market share)Chronic Growth11.1%13.3% (35% share, led Cardiac/Anti-Diabetic)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img